SG Americas Securities
TNDM icon

SG Americas Securities’s Tandem Diabetes Care TNDM Stock Holding History

SG Americas Securities’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-22,500
Closed -$46K – 3475
2020
Q3 		$46K Buy
22,500
+200
+0.9% +$21K ﹤0.01% 2529
2020
Q2 		$167K Buy
+22,300
New +$1.78M ﹤0.01% 3000

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SG Americas Securities's TNDM Position: Q1 2026 in Review

SG Americas Securities reduced its Tandem Diabetes Care (TNDM) stake by 47% in Q1 2026, selling an estimated $629K and leaving 33,022 shares worth $633K. The position accounts for ﹤0.01% of the portfolio, ranked #2048.

SG Americas Securities first reported a position in TNDM in Q3 2018 and has held it in 30 quarters since. The position peaked at $5.7M in Q2 2021. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • SG Americas Securities held 33,022 shares of Tandem Diabetes Care worth $633K as of Q1 2026.
  • SG Americas Securities sold 28,936 Tandem Diabetes Care shares in Q1 2026, an estimated $629K.
  • Tandem Diabetes Care made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #2048 holding.
  • SG Americas Securities first reported a position in Tandem Diabetes Care in Q3 2018 and has held it in 30 quarters since.
  • SG Americas Securities's Tandem Diabetes Care position peaked at $5.7M in Q2 2021.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.